Phase I and pharmacokinetic study of dasatinib and cetuximab in patients with advanced solid malignancies

Por Argiris, Athanassios, Feinstein, Trevor M., Wang, Lin, Yang, Tianbing, Agrawal, Shruti, Appleman, Leonard J., Stoller, Ronald G., Grandis, Jennifer R., Egloff, Ann Marie
Publicado em 2011

Phase I and Pharmacokinetic Study of Pegylated Liposomal CKD-602 (S-CKD602) in Patients with Advanced Malignancies

Por Zamboni, William C., Ramalingam, Suresh, Friedland, David M., Edwards, Robert P., Stoller, Ronald G., Strychor, Sandra, Maruca, Lauren, Zamboni, Beth A., Belani, Chandra P., Ramanathan, Ramesh K.
Publicado em 2009

Mechanism-based model characterizing bidirectional interaction between PEGylated liposomal CKD-602 (S-CKD602) and monocytes in cancer patients

Por Wu, Huali, Ramanathan, Ramesh K, Zamboni, Beth A, Strychor, Sandra, Ramalingam, Suresh, Edwards, Robert P, Friedland, David M, Stoller, Ronald G, Belani, Chandra P, Maruca, Lauren J, Bang, Yung-Jue, Zamboni, William C
Publicado em 2012

A phase I and pharmacokinetic study of oral 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in the treatment of advanced stage solid cancers – A California C...

Por Chao, Joseph, Synold, Timothy W., Morgan, Robert J., Kunos, Charles, Longmate, Jeff, Lenz, Heinz-Josef, Lim, Dean, Shibata, Stephen, Chung, Vincent, Stoller, Ronald G., Belani, Chandra P., Gandara, David R., McNamara, Mark, Gitlitz, Barbara J., Lau, Derick H., Ramalingam, Suresh S., Davies, Angela, Espinoza-Delgado, Igor, Newman, Edward M., Yen, Yun
Publicado em 2011